Aside from its potential to stimulate β-cell regeneration and prevent apoptosis, capability of CXCL12 to prevent pancreatic β-cells from entering the necrotic cell death by modulating PARP-1 activity, places chemokine CXCL12 in the focal point of developing strategies for diabetes treatment. Here, CXCL12 is linked to diabetes mellitus.